Stratification according to breast cancer clinical subtypes (22) showed that the CAP1 mRNA expression (Log2) was highest in the basal B subgroup with more mesenchymal-like cell lines, followed by the basal A and lowest among the luminal-like cell lines (P = 0.007; Figures 5A,B). This evidence concerns the gene CAP1 and breast carcinoma.